Neogen will announce results for the third quarter of its 2009 fiscal year, which ended on March 19. Neogen Reactivates Share Repurchase Program LANSING, Mich., / - / -- Neogen Corporation (Nasdaq.
Accordingly, there is no guarantee of the exact number of shares to be repurchased. Shares repurchased under the program will be retired. NEOG) announced today that on it initiated its current com stock repurchase program.
The company had 14,600,000 shares outstanding on. In December, Neogen's Board of Directors authorized the repurchase of up to 500,000 shares. Shares have been, and additional shares are expected to be, acquired on the open market or in negotiated transactions, depending on market conditions and other factors. "The price of Neogen shares is at the lowest level in nearly two years," said Llywellyn Herbert, Neogen's CEO. "We believe the price is an extraordinary value given the company's fundamentals and performance that have withstood the worst overall economy in decades." Neogen's second quarter was the 63rd consecutive profitable quarter from operations for the company, and the 67th quarter of the past 72 quarters to show increased revenues as compared with the previous year--a span of 18 years. |
sodium chloride injectable solution sodium chloride 09% bag rx (1000ml) muro 128 5% (sodium chloride hypertonicity) curasalt sodium chloride dressing, quantity pack of sodium chloride ophthalmic solution, usp 5% (15 ml) ballard unit dose saline 0.9% sodium chloride solution, 15ml vial, 144/cs mckesson 0.9% sodium chloride irrigation, usp, 250ml, 24/cs b braun sodium chloride pre-filled flush syringe, 0.9%, 5ml, 1000/cs 2 oz bottle of calcium chloride aquachek white test strip - sodium chloride - salt test |